Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Healthstream (HSTM) Shares Outstanding (Diluted Average) (2017 - 2026)

Healthstream has reported Shares Outstanding (Diluted Average) over the past 12 years, most recently at $30.1 million for Q4 2025.

  • Quarterly Shares Outstanding (Diluted Average) fell 1.31% to $30.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $30.1 million through Dec 2025, down 1.31% year-over-year, with the annual reading at $30.1 million for FY2025, 1.31% down from the prior year.
  • Shares Outstanding (Diluted Average) was $30.1 million for Q4 2025 at Healthstream, up from $29.8 million in the prior quarter.
  • Over five years, Shares Outstanding (Diluted Average) peaked at $31.7 million in Q3 2021 and troughed at $29.8 million in Q3 2025.
  • The 5-year median for Shares Outstanding (Diluted Average) is $30.7 million (2023), against an average of $30.8 million.
  • Year-over-year, Shares Outstanding (Diluted Average) dropped 3.49% in 2022 and then grew 0.67% in 2023.
  • A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $31.6 million in 2021, then fell by 2.85% to $30.7 million in 2022, then fell by 0.14% to $30.7 million in 2023, then dropped by 0.42% to $30.5 million in 2024, then decreased by 1.31% to $30.1 million in 2025.
  • Per Business Quant, the three most recent readings for HSTM's Shares Outstanding (Diluted Average) are $30.1 million (Q4 2025), $29.8 million (Q3 2025), and $30.4 million (Q2 2025).